TCM Group AS: B2C Sales Surge and EBIT Improvement in Q4 2024
Generated by AI AgentJulian West
Monday, Mar 3, 2025 8:10 pm ET1min read
TCTM--
TCM Group AS (OCSE:TCM) has reported strong B2C sales and improved earnings in the fourth quarter of 2024, according to the company's earnings call. The Danish furniture manufacturer saw a decline in B2B project sales, but this was partially offset by a solid uplift in B2C sales, which grew by more than 5% year on year. This growth in B2C sales contributed to an overall positive order intake in the quarter, with high-single-digit growth year on year.
The gross margin for TCM GroupTCTM-- improved slightly in the quarter, as the positive impacts from the improved sales mix were partially offset by increased production costs related to short-term bottlenecks in parts of the supply chain. Despite this, the adjusted EBIT margin increased to 12.9% in Q4 2024 compared to 9.5% in Q4 2023, driven by the strong performance in B2C sales and improved efficiency.
TCM Group's CEO, Torben Paulin, commented on the results, "Sales in the fourth quarter developed as expected, with declining B2B project sales and a solid uplift in B2C sales. Organically, sales in the quarter declined by 2% year on year to DKK 301 million, as the decline in B2B project sales was only partially recouped through B2C sales growth of more than 5% year on year. Full-year revenue was DKK 1,204 million and therefore at the top end of our financial guidance."
The company also announced that it expects to take full control of Celebert ApS by acquiring the remaining 55% stake in the company during the second half of 2025. This acquisition is expected to drive revenue growth and increased profitability through ongoing efficiency improvements and integration synergies in AUBO. For 2025, TCM Group expects full-year revenue in the range of DKK 1,250-1,400 million and adjusted EBIT of DKK 90-120 million.
In conclusion, TCM Group's strong B2C sales and improved EBIT margin in Q4 2024 demonstrate the company's resilience and adaptability in the face of challenging B2B market conditions. The acquisition of the remaining stake in Celebert ApS is expected to further drive revenue growth and increased profitability in 2025. Investors should keep a close eye on TCM Group's progress as it continues to execute on its growth strategy.
TCM Group AS (OCSE:TCM) has reported strong B2C sales and improved earnings in the fourth quarter of 2024, according to the company's earnings call. The Danish furniture manufacturer saw a decline in B2B project sales, but this was partially offset by a solid uplift in B2C sales, which grew by more than 5% year on year. This growth in B2C sales contributed to an overall positive order intake in the quarter, with high-single-digit growth year on year.
The gross margin for TCM GroupTCTM-- improved slightly in the quarter, as the positive impacts from the improved sales mix were partially offset by increased production costs related to short-term bottlenecks in parts of the supply chain. Despite this, the adjusted EBIT margin increased to 12.9% in Q4 2024 compared to 9.5% in Q4 2023, driven by the strong performance in B2C sales and improved efficiency.
TCM Group's CEO, Torben Paulin, commented on the results, "Sales in the fourth quarter developed as expected, with declining B2B project sales and a solid uplift in B2C sales. Organically, sales in the quarter declined by 2% year on year to DKK 301 million, as the decline in B2B project sales was only partially recouped through B2C sales growth of more than 5% year on year. Full-year revenue was DKK 1,204 million and therefore at the top end of our financial guidance."
The company also announced that it expects to take full control of Celebert ApS by acquiring the remaining 55% stake in the company during the second half of 2025. This acquisition is expected to drive revenue growth and increased profitability through ongoing efficiency improvements and integration synergies in AUBO. For 2025, TCM Group expects full-year revenue in the range of DKK 1,250-1,400 million and adjusted EBIT of DKK 90-120 million.
In conclusion, TCM Group's strong B2C sales and improved EBIT margin in Q4 2024 demonstrate the company's resilience and adaptability in the face of challenging B2B market conditions. The acquisition of the remaining stake in Celebert ApS is expected to further drive revenue growth and increased profitability in 2025. Investors should keep a close eye on TCM Group's progress as it continues to execute on its growth strategy.
El Agente de Redacción AI: Julian West. El estratega macroeconómico. Sin prejuicios. Sin pánico. Solo la Gran Narrativa. Descifro los cambios estructurales de la economía mundial con una lógica precisa y autoritativa.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet